A detailed history of Manufacturers Life Insurance Company, The transactions in Nevro Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 14,378 shares of NVRO stock, worth $64,988. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,378
Previous 14,802 2.86%
Holding current value
$64,988
Previous $124,000 35.48%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.71 - $10.1 $1,997 - $4,282
-424 Reduced 2.86%
14,378 $80,000
Q2 2024

Aug 14, 2024

BUY
$7.96 - $13.59 $12,736 - $21,744
1,600 Added 12.12%
14,802 $124,000
Q1 2024

May 14, 2024

SELL
$13.56 - $20.78 $9,180 - $14,068
-677 Reduced 4.88%
13,202 $190,000
Q3 2023

Nov 15, 2023

SELL
$18.22 - $25.85 $410,059 - $581,780
-22,506 Reduced 61.86%
13,879 $266,000
Q2 2023

Aug 11, 2023

BUY
$22.62 - $39.32 $47,253 - $82,139
2,089 Added 6.09%
36,385 $924,000
Q1 2023

May 15, 2023

BUY
$30.17 - $41.11 $422 - $575
14 Added 0.04%
34,310 $1.24 Million
Q4 2022

Aug 11, 2023

BUY
$36.43 - $49.4 $184,117 - $249,667
5,054 Added 17.28%
34,296 $1.36 Million
Q4 2022

Feb 13, 2023

BUY
$36.43 - $49.4 $184,117 - $249,667
5,054 Added 17.28%
34,296 $1.36 Million
Q3 2022

Aug 11, 2023

SELL
$40.66 - $53.03 $7,766 - $10,128
-191 Reduced 0.65%
29,242 $1.36 Million
Q3 2022

Nov 03, 2022

SELL
$40.66 - $53.03 $7,766 - $10,128
-191 Reduced 0.65%
29,242 $1.37 Million
Q2 2022

Aug 11, 2023

SELL
$40.85 - $77.67 $10,089 - $19,184
-247 Reduced 0.83%
29,433 $1.29 Million
Q2 2022

Aug 15, 2022

SELL
$40.85 - $77.67 $10,089 - $19,184
-247 Reduced 0.83%
29,433 $1.32 Million
Q1 2022

Aug 11, 2023

SELL
$59.95 - $92.06 $277,568 - $426,237
-4,630 Reduced 13.49%
29,680 $2.15 Million
Q1 2022

May 20, 2022

BUY
$59.95 - $92.06 $724,555 - $1.11 Million
12,086 Added 68.69%
29,680 $2.14 Million
Q4 2021

Feb 16, 2022

SELL
$81.07 - $121.29 $9,160 - $13,705
-113 Reduced 0.64%
17,594 $1.43 Million
Q3 2021

Nov 12, 2021

SELL
$101.99 - $166.36 $159,818 - $260,686
-1,567 Reduced 8.13%
17,707 $2.06 Million
Q2 2021

Aug 12, 2021

BUY
$141.6 - $179.06 $38,090 - $48,167
269 Added 1.42%
19,274 $3.2 Million
Q1 2021

May 03, 2021

SELL
$132.81 - $182.18 $152,864 - $209,689
-1,151 Reduced 5.71%
19,005 $2.65 Million
Q4 2020

Feb 12, 2021

BUY
$138.17 - $184.34 $127,116 - $169,592
920 Added 4.78%
20,156 $3.49 Million
Q3 2020

Nov 09, 2020

SELL
$114.09 - $145.51 $69,366 - $88,470
-608 Reduced 3.06%
19,236 $2.68 Million
Q2 2020

Aug 10, 2020

BUY
$89.45 - $129.85 $86,945 - $126,214
972 Added 5.15%
19,844 $2.34 Million
Q1 2020

May 15, 2020

SELL
$70.23 - $144.31 $4.54 Million - $9.32 Million
-64,615 Reduced 77.4%
18,872 $1.89 Million
Q4 2019

Feb 14, 2020

SELL
$76.41 - $117.54 $235,113 - $361,670
-3,077 Reduced 3.55%
83,487 $9.81 Million
Q3 2019

Nov 12, 2019

SELL
$61.52 - $91.1 $4.68 Million - $6.93 Million
-76,052 Reduced 46.77%
86,564 $7.31 Million
Q2 2019

Aug 14, 2019

SELL
$58.04 - $66.99 $38,712 - $44,682
-667 Reduced 0.41%
162,616 $10.5 Million
Q1 2019

May 13, 2019

SELL
$35.52 - $62.62 $4.37 Million - $7.71 Million
-123,050 Reduced 42.97%
163,283 $10.2 Million
Q4 2018

Feb 14, 2019

BUY
$35.43 - $56.29 $9.48 Million - $15.1 Million
267,556 Added 1424.91%
286,333 $11.1 Million
Q3 2018

Nov 14, 2018

SELL
$44.22 - $75.47 $113,247 - $193,278
-2,561 Reduced 12.0%
18,777 $1.07 Million
Q2 2018

Aug 14, 2018

BUY
$72.38 - $92.5 $34,670 - $44,307
479 Added 2.3%
21,338 $1.7 Million
Q1 2018

May 15, 2018

SELL
$69.46 - $88.57 $20,699 - $26,393
-298 Reduced 1.41%
20,859 $1.81 Million
Q4 2017

Feb 08, 2018

BUY
$65.94 - $93.31 $5,802 - $8,211
88 Added 0.42%
21,157 $1.46 Million
Q3 2017

Nov 14, 2017

BUY
$80.87 - $91.08 $1.7 Million - $1.92 Million
21,069
21,069 $1.92 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $160M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.